接受静脉-动脉体外膜氧合支持的大面积肺栓塞患者生存者与非生存者的回顾性比较
该单中心回顾性研究纳入2012年1月至2015年12月因确诊大面积肺栓塞接受VA-ECMO治疗的32例患者,比较生存者与非生存者的特征与结局。21例(65.6%)存活至撤机,17例(53.1%)存活至本次住院结束。生存者与非生存者在年龄、性别、右心室与左心室比值、肌钙蛋白T峰值方面无差异;非生存者倾向于有恶性肿瘤病史;ECMO置管前发生心搏骤停与更差结局相关。5例同时接受全身溶栓者全部死亡,15例接受导管定向溶栓者中11例存活;乳酸≤6mmol/L预测存活至出院的敏感度为82.4%、特异度为84.6%。作者认为应将ECMO保留给获益最大的患者,血乳酸>6mmol/L可能是预后不良的指标,导管定向溶栓在本组患者中与ECMO有效联合。
要点
- 32例大面积肺栓塞接受VA-ECMO者中,21例(65.6%)存活至撤机,17例(53.1%)存活至本次住院结束。
- ECMO置管前发生心搏骤停与更差结局相关;非生存者倾向于有恶性肿瘤病史。
- 5例同时接受全身溶栓者全部死亡,15例接受导管定向溶栓者中11例存活。
- 乳酸≤6mmol/L预测存活至出院的敏感度为82.4%、特异度为84.6%;作者认为血乳酸>6mmol/L可能是预后不良的指标。
- 作者认为ECMO应保留给获益最大的患者,灌注差(如心搏骤停)者从ECMO获益可能更少。
适用人群与场景
- 2012年1月至2015年12月在一家学术医学中心因确诊大面积肺栓塞接受VA-ECMO治疗的32例患者,肺栓塞均经计算机断层扫描和/或侵入性肺动脉造影确认。
- 本研究为单中心回顾性分析,评估ECMO治疗的大面积肺栓塞患者的短期死亡结局。
诊断标准与关键阈值
- 大面积肺栓塞经计算机断层扫描和/或侵入性肺动脉造影确认。
- 乳酸≤6mmol/L预测存活至出院的敏感度为82.4%、特异度为84.6%;作者认为血乳酸>6mmol/L可能是预后不良的指标。
红旗征与不能漏的情况
- ECMO置管前发生心搏骤停与更差结局相关。
- 作者认为灌注差(例如因心搏骤停所致)的患者从ECMO获益可能更少。
研究设计与关键结果
- 单中心回顾性分析纳入32例确诊大面积肺栓塞并接受VA-ECMO的患者,21例(65.6%)存活至撤机,17例(53.1%)存活至本次住院结束。
- 生存者与非生存者在年龄、性别、右心室与左心室比值、肌钙蛋白T峰值方面无差异。
- 非生存者倾向于有恶性肿瘤病史;ECMO置管前发生心搏骤停与更差结局相关。
- 5例同时接受全身溶栓者全部死亡,15例接受导管定向溶栓者中11例存活。
- 乳酸≤6mmol/L预测存活至出院的敏感度为82.4%、特异度为84.6%。
证据类型、等级与局限
- 证据类型:单中心回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,使用ECMO治疗大面积肺栓塞的实用方法是将其保留给获益最大的患者。
- 作者认为,灌注差(例如因心搏骤停所致)的患者从ECMO获益可能更少。
- 作者认为,血乳酸>6mmol/L可能是预后不良的指标。
- 作者报告,在其患者人群中导管定向溶栓药与ECMO有效联合。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: While the optimal care of patients with massive pulmonary embolism (PE) is unclear, the general goal of therapy is to rapidly correct the physiologic derangements propagated by obstructive clot. Extracorporeal membrane oxygenation (ECMO) in this setting is promising, however the paucity of data limits its routine use. Our institution expanded the role of ECMO as an advanced therapy option in the initial management of massive PE. The purpose of this project was to evaluate ECMO-treated patients with massive PE at an academic medical center and report shortterm mortality outcomes.
METHODS: Thirty-two patients placed on ECMO for confirmed, massive PE from January 2012 to December 2015 were retrospectively analyzed. All patients had PE confirmed by computerized tomography and/or invasive pulmonary angiography.
RESULTS: In our population of patients managed with ECMO, 21 (65.6%) patients survived to decannulation and 17 (53.1%) survived index hospitalization. Baseline characteristics and clinical variables showed no difference in age, gender, right ventricular-to-left ventricular ratios, or peak troponin-T between survivors and non-survivors. Non-survivors tended to have a previous history of malignancy. Cardiac arrest prior to ECMO cannulation was associated with worse outcomes. All 5 patients who received concomitant systemic thrombolysis died, while 11 of 15 patients who received catheter-directed thrombolysis survived. A lactic acid level ≤6mmol/L had an 82.4% sensitivity and 84.6% specificity for predicting survival to discharge.
CONCLUSION: The practical approach of utilizing ECMO for massive PE is to reserve it for those who would receive the greatest benefit. Patients with poor perfusion, for example from cardiac arrest, may gain less benefit from ECMO. Our findings indicate that a serum lactate >6mmol/L may be an indicator of worse prognosis. Finally, in our patient population, catheter-directed thrombolytics was effectively combined with ECMO.
参考来源
- George B, Parazino M, Omar HR, et al. A retrospective comparison of survivors and non-survivors of massive pulmonary embolism receiving veno-arterial extracorporeal membrane oxygenation support. Resuscitation. 2017. PMID: 29128608. doi:10.1016/j.resuscitation.2017.11.034
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。